SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-000155
Filing Date
2020-01-03
Accepted
2020-01-03 16:30:39
Documents
2
Period of Report
2020-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f8k010220_soligenixinc.htm 8-K 18162
2 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT DATED AS OF JANUARY 2, 2020, BETWEEN SO f8k010220ex10-1_soligenixinc.htm EX-10.1 14709
  Complete submission text file 0001213900-20-000155.txt   34375
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 20505929
SIC: 2834 Pharmaceutical Preparations